Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Methamphetamine Dependence (BUP PGx)
NCT00833443Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in methamphetamine use disorder (MUD), sponsored by University of California, Los Angeles. Started Jan 2009; status: completed.
02
Drugs
bupropion
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00833443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00833443.